News and Events

NJ Bio is thrilled to be a Senior Partner and Sponsor at the 13th World ADC Conference to be held in San Diego, California on September 6-9, 2022. The World ADC Conference is the most comprehensive and longest standing Antibody-Drug Conjugate Conference that provides...

PRINCETON, N.J.--(BUSINESS WIRE)--NJ Bio is procuring an 800 MHz NMR spectrometer with a cryogenic probe from JEOL. As part of this collaboration, NJ Bio will contribute its expertise in antibody drug conjugates, oligonucleotide conjugates, and other chemistries to...

Princeton, NJ – NJ Biopharmaceutical (d/b/a NJ Bio), a global provider of outsourced integrated chemistry and biology services to clients in the pharmaceutical and biotechnology industries was awarded the Best Contract Research Provider Award, 2021 at the 8th Annual...

NJ Biopharmaceuticals LLC (d/b/a NJ Bio), an expert provider of chemistry and biopharmaceutical services welcomed the appointments of Ilan Kaufthal as Senior Advisor, and Ronald Gold, Steven Klosk, and Chetan Jain to its Board of Directors. Ilan, Ron, Steve and Chetan...

NJ Bio, an expert in bioconjugation, nucleotide chemistry, custom synthesis, flow chemistry and process development, and application of BioNMR to drug discovery programs, is moving to new, state-of-the-art headquarters in Princeton, NJ.

NJ Bio has published a review article on Antibody-Oligonucleotide Conjugates. Dugal-Tessier, J.; Thirumalairajan, S.; Jain, N. Antibody-Oligonucleotide Conjugates: A Twist to Antibody-Drug Conjugates. J. Clin. Med 2021,10, 838. https://doi.org/10.3390/jcm10040838...

North Brunswick, NJ and Bristol, PA — NJ Biopharmaceuticals LLC (d/b/a NJ Bio), a CRO providing integrated chemistry and biology services, was awarded Runner Up in the Best Contract Research Provider category at the 7th Annual World ADC Awards. The Best CRO Provider...

NJ Bio would like to share that Dr. Naresh Jain, NJ Bio’s President & CEO, and Dr. Julien Dugal-Tessier, NJ Bio’s Director of Innovative Chemistry and Innovation, will hold a Workshop at the 10th Annual World ADC London 2020. The workshop will be titled “The...

Dr. Naresh Jain, NJ Bio’s President & CEO, has been presented with this year’s UAA-ICT Distinguished Alumnus Award in the Research Category by the UDCT Alumni Association (UAA). This prestigious award, given out annually in five categories, was awarded to Dr. Jain...

NJ Bio is pleased to announce that Dr. Jagath Reddy Junutula and Dr Zhihua Sui two well-known and esteemed industry experts in oncology drug discovery (including ADCs) and medicinal chemistry/drug discovery, respectively, have joined NJ Bio’s Scientific Advisory Board...

NJ Bio will exhibit at the 10th annual World ADC 2019 in San Diego, CA, from October 10 – 11, 2019. World ADC, organized by Hanson Wade, is the longest standing and most comprehensive antibody-drug conjugate meeting. Please visit us at our booth to discuss...

Dr. Naresh Jain, President & CEO of NJ Bio, will speak of Friday, October 11, 2019, at 9:10 am at World ADC 2019 in San Diego. The topic of Dr. Jain’s talk will be “Protoxins: The Next Generation of Toxins for Antibody-Drug Conjugates.” The presentation will cover...

Philadelphia Regional Integrated Medicine Alliance (“PRIMA”) NJ Biop has joined the Greater Philadelphia Regional Integrated Medicine Alliance (PRIMA). PRIMA is a regional, integrated and virtual public/private partnership focused exclusively on nurturing the region’s...

NJ Bio will exhibit at The BIO International Convention (BIO) in Philadelphia, PA, from June 4 – 6, 2019. This convention attracts more than 16,000 biotechnology and pharma leaders and brings together a wide spectrum of life science and application areas including...